Cargando…
NFKB1 and Cancer: Friend or Foe?
Current evidence strongly suggests that aberrant activation of the NF-κB signalling pathway is associated with carcinogenesis. A number of key cellular processes are governed by the effectors of this pathway, including immune responses and apoptosis, both crucial in the development of cancer. Theref...
Autores principales: | Concetti, Julia, Wilson, Caroline L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6162711/ https://www.ncbi.nlm.nih.gov/pubmed/30205516 http://dx.doi.org/10.3390/cells7090133 |
Ejemplares similares
-
ZEB Proteins in Leukemia: Friends, Foes, or Friendly Foes?
por: Soen, Bieke, et al.
Publicado: (2018) -
Fibronectin in Cancer: Friend or Foe
por: Lin, Tsung-Cheng, et al.
Publicado: (2019) -
Pyroptosis in Cancer: Friend or Foe?
por: Lu, Xiuxia, et al.
Publicado: (2021) -
PGC1α: Friend or Foe in Cancer?
por: Mastropasqua, Francesca, et al.
Publicado: (2018) -
STAT3 in Cancer—Friend or Foe?
por: Zhang, Hai-Feng, et al.
Publicado: (2014)